caymanryu- I saw you on AMZN board and you were long in $600's how that work out for ya?
FIT Earnings Date
Earnings announcement* for FIT: Feb 01, 2016
Fitbit, Inc. to report earnings on 02/01/2016.
Capital Market Laboratories
WHAT JUST HAPPENED
We thought Relypsa would released data that could limit the blackbox label to three hours rather than six. We just found out the entire blackbox could go away.
Relypsa Announces Results From Veltassa Drug-Drug Interaction Studies in Healthy Volunteers. Here are the details.
Relypsa reports results from Phase 1 in vivo studies in healthy volunteers evaluating potential drug-drug interactions between Veltassa and 12 drugs administered either at the same time or three hours apart
1. Results of the Phase 1 studies showed nine of the 12 drugs tested showed no clinically meaningful reduction in absorption when administered at the same time as Veltassa
2. No reduction in absorption was observed for any of the 12 drugs tested with a three-hour dosing separation from Veltassa
Sarepta Plunges on Harsh FDA Eteplirsen Review Ahead of Next Week's Advisory Panel Meeting
| 01/15/16 - 09:29 AM EST
Exclusive FREE Report: Jim Cramer's Best Stocks for 2016
Sarepta Therapeutics' (SRPT) stock price plummeted Friday on a very negative clinical review of the company's Duchenne muscular dystrophy drug eteplirsen released by the U.S. Food and Drug Administration.
A lot of people apparently got Fitbits for Christmas
The app shot up 20 spots to the top of the "free apps" list in the App Store.
By: Dana Wollman
If Apple's App Store rankings are any indication, a lot of you got a Fitbit for Christmas yesterday: The company's fitness-tracking app quickly shot to the top of the free list in iTunes. As Qz points out, Fitbit's activity tracker was already the most-downloaded health and fitness application for iOS, but as Christmas approached, it leapfrogged 20 spots to the top, suggesting many a couch potato unboxed one of the firm's wristbands.That's not surprising, insofar as Fitbit is the clear market leader. cConsider this evidence that Fitbit is still a first name in wearables -- and that lots of gift givers had the same safe idea.
Buyer on Friday. This is one great company.
The Fly On The Wall
SunEdison, TerraForm Power analyst commentary at UBS
SunEdison debt paydowm comes with cost, says UBS. UBS analyst Julien Dumoulin-Smith says SunEdison's (SUNE) announcement yesterday regarding the paydown of 2020 notes early comes at a cost. The debt paydown accompanies another delay of payments into late 2016 of earnouts due to FirstWind for the bulk of the $125M previously contemplated for Q1, as well as corresponding reduction in interest expense, Dumoulin-Smith says in a New Year's Eve research note titled "Selling the House to Paydown Debt." While reducing near-term liquidity needs, SunEdison will lose 12M of its readily-saleable shares in
TerraForm Power (TERP), the analyst contends. He maintains a Sell rating on SunEdison with a $2 price target.
FDA clarifies the line between wellness and regulated medical devices
By Brian Dolan
January 16, 2015
$26 ??? Undervalued, This Co Makes Millions of Profit revenue
Just Googled how many people get Pneumonia in united States Each Year, This Is Correct.
Sentiment: Strong Buy
3 Reasons to Own Shake Shack Stock
By Brian Sozz